Two academics from a prestigious Australian medical research...

Two academics from a prestigious Australian medical research centres are clashing over a prospectus claim. The issue involves the float on 24 January of Biotron, a medical research company, founded by John Curtin School of Medical Research (JCSMR) professor, Peter Gage. Biotron's prospectus, used to raise $A12 million, refers to the development of anti-viral agents to block ion channels that carry viruses, such as those causing dengue and Ross River fevers. Fellow JCSMR professor, Graeme Laver, from the institute's biochemistry and molecular biology division, has complained to the Australian Securities and Investments Commission that there is no proof these particular viruses possess ion channels

The claim was dismissed because it did not contavene ASIC guidelines but what about the Ion exchange?